173 related articles for article (PubMed ID: 27246399)
1. Pharmacological inhibition of MyD88 homodimerization counteracts renal ischemia reperfusion-induced progressive renal injury in vivo and in vitro.
Zhang LM; Liu JH; Xue CB; Li MQ; Xing S; Zhang X; He WT; Jiang FC; Lu X; Zhou P
Sci Rep; 2016 Jun; 6():26954. PubMed ID: 27246399
[TBL] [Abstract][Full Text] [Related]
2. A Novel Inhibitor of Homodimerization Targeting MyD88 Ameliorates Renal Interstitial Fibrosis by Counteracting TGF-β1-Induced EMT in Vivo and in Vitro.
Liu JH; He L; Zou ZM; Ding ZC; Zhang X; Wang H; Zhou P; Xie L; Xing S; Yi CZ
Kidney Blood Press Res; 2018; 43(5):1677-1687. PubMed ID: 30380557
[TBL] [Abstract][Full Text] [Related]
3. Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.
Li C; Zhang LM; Zhang X; Huang X; Liu Y; Li MQ; Xing S; Yang T; Xie L; Jiang FC; Jiang HY; He WT; Zhou P
Transplantation; 2017 Feb; 101(2):284-293. PubMed ID: 27607533
[TBL] [Abstract][Full Text] [Related]
4. Targeting of MyD88 Homodimerization by Novel Synthetic Inhibitor TJ-M2010-5 in Preventing Colitis-Associated Colorectal Cancer.
Xie L; Jiang FC; Zhang LM; He WT; Liu JH; Li MQ; Zhang X; Xing S; Guo H; Zhou P
J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26712311
[TBL] [Abstract][Full Text] [Related]
5. Beyond knockout: A novel homodimerization-targeting MyD88 inhibitor prevents and cures type 1 diabetes in NOD mice.
Zhang X; Xing S; Li M; Zhang L; Xie L; He W; Liu J; Chang S; Jiang F; Zhou P
Metabolism; 2016 Sep; 65(9):1267-77. PubMed ID: 27506734
[TBL] [Abstract][Full Text] [Related]
6. Short-term use of MyD88 inhibitor TJ-M2010-5 prevents d-galactosamine/lipopolysaccharide-induced acute liver injury in mice.
Ding Z; Du D; Yang Y; Yang M; Miao Y; Zou Z; Zhang X; Li Z; Zhang X; Zhang L; Wang X; Zhao Y; Jiang J; Jiang F; Zhou P
Int Immunopharmacol; 2019 Feb; 67():356-365. PubMed ID: 30583234
[TBL] [Abstract][Full Text] [Related]
7. Modulating the conformation of the TIR domain by a neoteric MyD88 inhibitor leads to the separation of GVHD from GVT.
Xing S; Zhang X; Huang X; Xie L; Jiang F; Zhou P
Leuk Lymphoma; 2019 Jun; 60(6):1528-1539. PubMed ID: 30501537
[TBL] [Abstract][Full Text] [Related]
8. TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo.
Yang H; Zhou P; Li Q; Zhou X; Li J; Wang J; Wang J; Zhao Y; Yang B; Zhang B; Dai C; Zou Z; Yang Y; Chen Z
J Cardiovasc Transl Res; 2022 Dec; 15(6):1366-1376. PubMed ID: 35411418
[TBL] [Abstract][Full Text] [Related]
9. The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3β and MyD88/NF-κB signalling pathways.
Liu JH; Chen C; Li ZY; Zou ZM; Gao DC; Zhang X; Kuang XW; Sun ZH; Zheng WJ; Zhou P; Sun SR
Exp Cell Res; 2020 Sep; 394(2):112157. PubMed ID: 32610185
[TBL] [Abstract][Full Text] [Related]
10. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.
Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P
Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390
[TBL] [Abstract][Full Text] [Related]
11. TJ-M2010-5, a novel MyD88 inhibitor, corrects R848-induced lupus-like immune disorders of B cells in vitro.
Zou Z; Du D; Miao Y; Yang Y; Xie Y; Li Z; Zhou L; Zhang L; Zhou P; Jiang F
Int Immunopharmacol; 2020 Aug; 85():106648. PubMed ID: 32504998
[TBL] [Abstract][Full Text] [Related]
12. Hypothermic oxygenated perfusion combined with TJ-M2010-5 alleviates hepatic ischemia-reperfusion injury in donation after circulatory death.
Zhou W; Peng S; Du P; Zhou P; Xue C; Ye Q
Int Immunopharmacol; 2022 Apr; 105():108541. PubMed ID: 35063749
[TBL] [Abstract][Full Text] [Related]
13. Treatment of a MyD88 inhibitor alleviates rejection and inflammation in xenotransplantation by inhibiting dendritic cells activation and trained immunity in macrophages.
Li Z; Zhao M; Yang Y; Zou Z; Zhang L; Jiang F; Du D; Zhou P
Int Immunopharmacol; 2024 Mar; 130():111664. PubMed ID: 38377850
[TBL] [Abstract][Full Text] [Related]
14. The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury.
Li M; Khan AM; Maderdrut JL; Simon EE; Batuman V
Am J Nephrol; 2010; 32(6):522-32. PubMed ID: 20980738
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury.
Pulskens WP; Teske GJ; Butter LM; Roelofs JJ; van der Poll T; Florquin S; Leemans JC
PLoS One; 2008; 3(10):e3596. PubMed ID: 18974879
[TBL] [Abstract][Full Text] [Related]
16. TJ-M2010-5, a novel CNS drug candidate, attenuates acute cerebral ischemia-reperfusion injury through the MyD88/NF-κB and ERK pathway.
Li Z; Zhao M; Zhang X; Lu Y; Yang Y; Xie Y; Zou Z; Zhou L; Shang R; Zhang L; Jiang F; Du D; Zhou P
Front Pharmacol; 2022; 13():1080438. PubMed ID: 36588708
[No Abstract] [Full Text] [Related]
17. The Novel MyD88 Inhibitor TJ-M2010-5 Protects Against Hepatic Ischemia-reperfusion Injury by Suppressing Pyroptosis in Mice.
Zou Z; Shang R; Zhou L; Du D; Yang Y; Xie Y; Li Z; Zhao M; Jiang F; Zhang L; Zhou P
Transplantation; 2023 Feb; 107(2):392-404. PubMed ID: 36226835
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MyD88 by a novel inhibitor reverses two-thirds of the infarct area in myocardial ischemia and reperfusion injury.
Miao Y; Ding Z; Zou Z; Yang Y; Yang M; Zhang X; Li Z; Zhou L; Zhang L; Zhang X; Du D; Jiang F; Zhou P
Am J Transl Res; 2020; 12(9):5151-5169. PubMed ID: 33042411
[TBL] [Abstract][Full Text] [Related]
19. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells.
Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J
Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3 inhibition attenuates fibroblast activation and development of fibrosis following renal ischemia-reperfusion in mice.
Singh SP; Tao S; Fields TA; Webb S; Harris RC; Rao R
Dis Model Mech; 2015 Aug; 8(8):931-40. PubMed ID: 26092126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
